These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 8672510
41. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies. Weir MP, Bethell SS, Cleasby A, Campbell CJ, Dennis RJ, Dix CJ, Finch H, Jhoti H, Mooney CJ, Patel S, Tang CM, Ward M, Wonacott AJ, Wharton CW. Biochemistry; 1998 May 12; 37(19):6645-57. PubMed ID: 9578548 [Abstract] [Full Text] [Related]
47. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study. Casale E, Collyer C, Ascenzi P, Balliano G, Milla P, Viola F, Fasano M, Menegatti E, Bolognesi M. Biophys Chem; 1995 Mar 22; 54(1):75-81. PubMed ID: 7703351 [Abstract] [Full Text] [Related]
48. Thermodynamics of substrates and reversible inhibitors binding to the active site cleft of human alpha-thrombin. De Cristofaro R, Landolfi R. J Mol Biol; 1994 Jun 17; 239(4):569-77. PubMed ID: 8006969 [Abstract] [Full Text] [Related]
54. Molecular cloning and antifibrinolytic activity of a serine protease inhibitor from bumblebee (Bombus terrestris) venom. Qiu Y, Lee KS, Choo YM, Kong D, Yoon HJ, Jin BR. Toxicon; 2013 Mar 01; 63():1-6. PubMed ID: 23164714 [Abstract] [Full Text] [Related]
55. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases. Scott CF, Wenzel HR, Tschesche HR, Colman RW. Blood; 1987 May 01; 69(5):1431-6. PubMed ID: 2436687 [Abstract] [Full Text] [Related]
57. Plasma kallikrein inhibitors in bovine plasma. Halkier T, Markussen S, Muldbjerg M. Blood Coagul Fibrinolysis; 1994 Aug 01; 5(4):655-6. PubMed ID: 7841325 [No Abstract] [Full Text] [Related]
58. Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library. de Veer SJ, Wang CK, Harris JM, Craik DJ, Swedberg JE. J Med Chem; 2015 Oct 22; 58(20):8257-68. PubMed ID: 26393374 [Abstract] [Full Text] [Related]
59. Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases. Baeriswyl V, Heinis C. Protein Eng Des Sel; 2013 Jan 22; 26(1):81-9. PubMed ID: 23100545 [Abstract] [Full Text] [Related]
60. Homology modelling of rat kallikrein rK9, a member of the tissue kallikrein family: implications for substrate specificity and inhibitor binding. Moreau T, Gauthier F. Protein Eng; 1996 Nov 22; 9(11):987-95. PubMed ID: 8961351 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]